Published on Saturday June 06, 2020

Smooth Drug Development May 2020 News Release

We were working on the following new projects in May:
Smooth Drug Development signed several contracts for medical writing
We signed a contract for organization of phase III clinical trial with INN: Buserelinum
We are negotiating an agreement for pharmacovigilance activities.

Clinical Department News
Clinical study report was prepared for erlotinib project.
Site Selection visits are being performed by our team in COVID-19 trial.
Close out visits were performed in Lopinavir and Ritonavir project
Enrollment in flu vaccine study is completed ahead of schedule

Our BD plans to participate in Bio Virtual Partnering conference